CYCC
Cyclacel Pharmaceuticals is a biopharmaceutical company focused on developing innovative cancer therapies. Specializing in cell cycle biology, it designs targeted treatments for various cancers, including hematological malignancies and solid tumors. The company leverages its expertise in molecular biology to advance novel drug candidates through clinical trials, aiming to improve outcomes for patients with limited treatment options. Its research emphasizes precision medicine, targeting specific pathways involved in cancer progression. Cyclacel collaborates with academic and industry partners to accelerate drug development and bring cutting-edge therapies to market. The company is committed to addressing unmet medical needs in oncology through science-driven innovation.
| Name | CIK | Position |
|---|---|---|
| loading... | ||